Research Library
PRECLINICAL

5-Amino-1MQ

Also known as: 5-Amino-1-methylquinolinium, 5-Amino-1MQ

Metabolic SignalingCellular Stress
ClassificationSmall-molecule NNMT (nicotinamide N-methyltransferase) inhibitor.
Catalog / SKU5-Amino-1MQ · MX-5AMINO1M-010 · 10 mg
TargetsNicotinamide N-methyltransferase (NNMT)

Molecular Overview

5-Amino-1MQ is a small-molecule inhibitor of NNMT that has been used in preclinical metabolic research to probe NNMT-related pathways and cellular NAD/methylation biology.

Mechanistic Background

Inhibition of NNMT is studied in the context of cellular metabolism and adipocyte biology in experimental models.

What Researchers Study

Preclinical research has examined NNMT inhibition and its metabolic consequences in cell and rodent models.

Evidence Landscape

Current evidence level: PRECLINICAL. Preclinical evidence does not equate to demonstrated human efficacy.

Research Limitations

Evidence is preclinical; human characterization is limited.

Research Use Only

Molecularix Biolabs provides research materials for legitimate laboratory research. Information in this Research Library is provided for educational and scientific reference purposes and is not medical advice, treatment guidance, or a recommendation for human or veterinary use.